首页> 美国卫生研究院文献>Materials >Antithrombogenicity of Fluorinated Diamond-Like Carbon Films Coated Nano Porous Polyethersulfone (PES) Membrane
【2h】

Antithrombogenicity of Fluorinated Diamond-Like Carbon Films Coated Nano Porous Polyethersulfone (PES) Membrane

机译:氟化类金刚石碳膜包覆的纳米多孔聚醚砜(PES)膜的抗血栓形成性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A nano porous polyethersulfone (PES) membrane is widely used for aspects of nanofiltration, such as purification, fractionation and dialysis. However, the low-blood-compatibility characteristic of PES membrane causes platelets and blood cells to stick to the surface of the membrane and degrades ions diffusion through membrane, which further limits its application for dialysis systems. In this study, we deposited the fluorinated-diamond-like-carbon (F-DLC) onto the finger like structure layer of the PES membrane. By doing this, we have the F-DLC films coating the membrane surface without sacrificing the membrane permeability. In addition, we examined antithrombogenicity of the F-DLC/PES membranes using a microfluidic device, and experimentally found that F-DLC drastically reduced the amount of blood cells attached to the surface. We have also conducted long-term experiments for 24 days and the diffusion characteristics were found to be deteriorated due to fouling without any surface modification. On the other hand, the membranes coated by F-DLC film gave a consistent diffusion coefficient of ions transfer through a membrane porous. Therefore, F-DLC films can be a great candidate to improve the antithrombogenic characteristics of the membrane surfaces in hemodialysis systems.
机译:纳米多孔聚醚砜(PES)膜被广泛用于纳滤的各个方面,例如纯化,分馏和渗析。然而,PES膜的低血液相容性特征会导致血小板和血细胞粘附在膜表面,并降低离子通过膜的扩散,这进一步限制了其在透析系统中的应用。在这项研究中,我们将氟化钻石状碳(F-DLC)沉积到PES膜的手指状结构层上。通过这样做,我们可以在不牺牲膜渗透性的情况下使F-DLC膜覆盖膜表面。此外,我们使用微流体装置检查了F-DLC / PES膜的抗血栓形成性,并通过实验发现F-DLC大大减少了附着在表面的血细胞数量。我们还进行了24天的长期实验,发现扩散特性由于没有任何表面改性的结垢而恶化。另一方面,用F-DLC膜涂覆的膜给出了穿过膜多孔膜的离子传递的恒定扩散系数。因此,F-DLC膜可能是改善血液透析系统中膜表面抗血栓形成特性的理想选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号